The Journal for Nurse Practitioners
Volume 4, Issue 9 , Pages 673-680 , October 2008

Management of Cardiometabolic Syndrome in the Primary and Secondary Prevention of Cardiovascular Disease

  • M. Dominique Ashen

      Affiliations

    • M. Dominique Ashen, PhD, CRNP, is the nurse practitioner coordinator for the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease in Baltimore, Maryland, with a joint appointment as an assistant professor in the Johns Hopkins University School of Nursing.

References 

  1. Expert Panel on Detection  , Evaluation and Treatment of High Blood Cholesterol in Adults  . Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) . JAMA . 2001;285:2486–2497
  2. Grundy SM , Cleeman JI , Bairey Merz CN , et al.   Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines . Circulation . 2004;110:227–239
  3. National Cholesterol Education Program (NCEP) Expert Panel on Detection  , Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)  . Third report on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report . Circulation . 2002;106:3143–3421
  4. Wilson PWF , D'Agostino RB , Parise H , Sullivan L , Meigs JB . Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus . Circulation . 2005;112(20):3066–3072
  5. Hanley AJG , Festa A , D'Agostino RB , Wagenknecht LE , Savage PJ , et al.   Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity . Diabetes . 2004;53:1773–1781
  6. Ford ES . Risk for all-cause mortality, cardiovascular disease and diabetes associated with the metabolic syndrome: a summary of the evidence . Diabetes Care . 2005;28:1769–1778
  7. Grundy SM , Cleeman JI , Daniels SR , Donato KA , Eckel RH , et al.   Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement . Circulation . 2005;112:2735–2752
  8. Alexander CM , Landsman PB , Teutsch SM , Haffner SM . Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP defined metabolic syndrome, diabetes and prevalence of coronary heart disease among NHANES III participants age 50 years and older . Diabetes . 2003;52:1210–1214
  9. Nesto RW . Correlation between cardiovascular disease and diabetes mellitus: current concepts . Am J Med . 2004;116(suppl 5A):11s–22s
  10. Gami AS , Witt BJ , Howard DE , Erwin PJ , Gami LA , et al.   Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies . J Am Coll Cardiol . 2007;49:403–414
  11. Ford ES , Giles WH , Dietz WH . Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey . JAMA . 2002;287:356–359
  12. Ford ES , Giles WH , Mokdad AH . Increasing prevalence of the metabolic syndrome among US Adults . Diabetes Care . 2004;27:2444–2449
  13. Lemieux I , Pascot A , Couillard C , Lamarche B , Tchernof A , et al.   Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small dense LDL-C) in men? . Circulation . 2000;102:179–184
  14. Carr DB , Utzschneider KM , Hull RL , Kodama K , Retzlaff BM , et al.   Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome . Diabetes . 2004;53:2087–2094
  15. Reaven GM . Banting lecture 1988. Role of insulin resistance in human disease . Diabetes . 1988;37:1595–1607
  16. Ferrannini E , Haffner SM , Mitchell BD , Stern MP . Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome . Diabetologia . 1991;34:416–422
  17. Berneis KK , Krauss RM . Metabolic origins and clinical significance of LDL-C heterogeneity . J Lipid Res . 2002;43:1363–1379
  18. von Eckardstein A , Hersberger M , Rohrer L . Current understanding of the metabolic and biological actions of HDL-C . Curr Opin Clin Nutr Metab Care . 2005;8:147–152
  19. Jellinger PS . Metabolic consequences of hyperglycemia and insulin resistance . Clin Cornerstone . 2007;8:S30–S42
  20. Chobanian AV , Bakris GL , Black HR , Cushman WC , Green LA , et al.   National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC 7 Report . JAMA . 2003;289:2560–2572
  21. Aronson D , Rayfield EJ . How hyperglycemia promotes atherosclerosis: molecular mechanisms . Cardiovasc Diabetol . 2002;1:1–10
  22. Juhan-Vague I , Morange PE , Alessi MC . The insulin resistance syndrome: implications for thrombosis and cardiovascular disease . Pathophysiol Haemost Thromb . 2002;32:269–273
  23. Eckel RH , Grundy SM , Zimmet PZ . The metabolic syndrome . Lancet . 2005;365:1415–1420
  24. Wellen KE , Hotamisligil GS . Obesity induced inflammatory changes in adipose tissue . J Clin Investig . 2003;112:1785–1788
  25. Ross R . Atherosclerosis – an inflammatory disease . NEJM . 1999;340:115–126
  26. Pollex RL , Hegele RA . Genetic determinants of the metabolic syndrome . Nat Clin Pract . 2006;3:482–489
  27. WHO  . Report of a WHO consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus . Available at: http://www.staff.newcastle.ac.uk/phillip.home/who_dmc.htm Last accessed June 15, 2008.
  28. George K , Alberti MM , Zimmet P , Shaw J . The metabolic syndrome – a new worldwide definition . Lancet . 2005;366:1059–1062
  29. Hunt KJ , Resendez RG , Williams K , Haffner SM , Stern MP . National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study . Circulation . 2004;110:1251–1257
  30. Lorenzo L , Williams K , Hunt KJ , Haffner SM . The National Cholesterol Education Program Adult Treatment Panel III, International Diabetes Foundation and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes . Diabetes Care . 2007;30(1):8–13
  31. Davis S . Evolving treatments for cardiometabolic syndrome . Manag Care Med . 2006;9:17–21
  32. Michos ED , Nasir K , Braunstein JB , Rumberger JA , Budoff MJ , et al.   Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women . Atherosclerosis . 2006;184:201–206
  33. Santos RD , Nasir K , Tufail K , Meneghelo RS , Carvalho JAM , et al.   Metabolic syndrome is associated with coronary artery calcium in asymptomatic white Brazilian men considered low-risk by Framingham risk score . Prev Cardiol . 2007;10(3):141–146
  34. Shaw LJ , Raggi P , Schisterman E , Berman DS , Callister TQ . Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality . Radiology . 2003;228(3):826–833
  35. Wang TJ , Larson MG , Levy D , Benjamin EJ , Kupka MK , et al.   C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study . Circulation . 2002;106:1189–1191
  36. Nassis GP , Papantakou K , Skenderi K , Triandafillopoulou M , Kavouras SA , et al.   Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin and inflammatory markers in overweight and obese girls . Metabolism . 2005;54:1472–1479
  37. LaMonte MJ , Barlow CE , Jurca R , Kampert JB , Church TS , et al.   Cardiorespiratory fitness is inversely associated with the incidence of metabolic syndrome: a prospective study of men and women . Circulation . 2005;112(4):505–512
  38. Lopez-Garcia E , Schulze MB , Fung TT , Meigs JB , Rifai N , et al.   Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction . Am J Clin Nutr . 2004;80(4):1029–1035
  39. Esposito K , Marfella R , Ciotola M , Di Palo C , Giugliano F , et al.   Effect of Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial . JAMA . 2004;292:1440–1446
  40. Ebbeling CB , Leidig MM , Feldman HA , Lovesky MM , Ludwig DS . Effects of a low-glycemic load vs low fat diet in obese young adults: a randomized trial . JAMA . 2007;297(19):2012–2092
  41. Available at: www.nhlbi.nih.gov/health/public/heart/obesity/lose_wt/behavior.htm Last accessed June 15, 2008.
  42. American Diabetes Association  . Clinical practice recommendations . Diabetes Care . 2005;28(Suppl 1):s1–s9
  43. Smith SC , Blair SN , Bonow RO , Brass LM , Cerqueira MD , et al.   AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic vascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology . Circulation . 2001;104:1577–1579
  44. Pearson TA , Blair SN , Daniels SR , Eckel RH , Fair JM , et al.   AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee . Circulation . 2002;106:388–391
  45. National Institutes of Health  . Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults – the evidence report . Obes Res . 1998;6(Suppl 2):51S–209S
  46. Ridker PM , Cook NR , Lee IM , Gordon D , Gaziano JM , et al.   A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women . N Engl J Med . 2005;352:1293–1304
  47. Mosca L , Banka CL , Benjamin EJ , Berra K , Bushnell C , et al.   Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update . Circulation . 2007;115:1481–1501
  48. Yusuf S , Gerstein H , Hoogwerf B , Pogue J , Bosch J , et al.   Ramapril and the development of diabetes . JAMA . 2001;286:1882–1885
  49. Lindholm LH , Ibsen H , Borch-Johnsen K , Olsen MH , Wachtell K , et al.   Risk of new-onset diabetes in the Losartan Intervention For Endpoint Reduction in Hypertension Study . J Hypertens . 2002;20(9):1879–1886
  50. Kjeldsen S , Julius S , Mancia G , McInnes G , Hua T , et al.   Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high risk hypertensive patients: the VALUE trial . J Hypertens . 2006;24(7):1045–1412

 In compliance with national ethical guidelines, the author reports no relationships with business or industry that would pose a conflict of interest.

PII: S1555-4155(08)00410-8

doi: 10.1016/j.nurpra.2008.07.018

The Journal for Nurse Practitioners
Volume 4, Issue 9 , Pages 673-680 , October 2008

Article Tools

* Image Usage & Resolution